SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000920465-16-000098
Filing Date
2016-01-11
Accepted
2016-01-11 16:39:44
Documents
4
Period of Report
2016-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_145254837268238.html 3  
1 FORM 3 wf-form3_145254837268238.xml 3 10088
2 CARVER POA carverpoa.htm EX-24 861
3 CARVER POA IMAGE 1 carverpoa001.jpg GRAPHIC 199715
4 CARVER POA IMAGE 2 carverpoa002.jpg GRAPHIC 26171
  Complete submission text file 0000920465-16-000098.txt   322434
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 725 NEWPORT STREET DENVER CO 80220
Business Address
CARVER JENNIFER (Reporting) CIK: 0001663163 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36282 | Film No.: 161336786